183 related articles for article (PubMed ID: 23918218)
1. Imaging features of sporadic breast cancer in women under 40 years old: 97 cases.
Bullier B; MacGrogan G; Bonnefoi H; Hurtevent-Labrot G; Lhomme E; Brouste V; Boisserie-Lacroix M
Eur Radiol; 2013 Dec; 23(12):3237-45. PubMed ID: 23918218
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer in very young women (<30 years): Correlation of imaging features with clinicopathological features and immunohistochemical subtypes.
An YY; Kim SH; Kang BJ; Park CS; Jung NY; Kim JY
Eur J Radiol; 2015 Oct; 84(10):1894-902. PubMed ID: 26198117
[TBL] [Abstract][Full Text] [Related]
3. Radiological features of triple-negative breast cancers (73 cases).
Boisserie-Lacroix M; Mac Grogan G; Debled M; Ferron S; Asad-Syed M; Brouste V; Mathoulin-Pelissier S; Hurtevent-Labrot G
Diagn Interv Imaging; 2012 Mar; 93(3):183-90. PubMed ID: 22421282
[TBL] [Abstract][Full Text] [Related]
4. Triple-negative breast cancers: associations between imaging and pathological findings for triple-negative tumors compared with hormone receptor-positive/human epidermal growth factor receptor-2-negative breast cancers.
Boisserie-Lacroix M; Macgrogan G; Debled M; Ferron S; Asad-Syed M; McKelvie-Sebileau P; Mathoulin-Pélissier S; Brouste V; Hurtevent-Labrot G
Oncologist; 2013; 18(7):802-11. PubMed ID: 23821326
[TBL] [Abstract][Full Text] [Related]
5. The biology of malignant breast tumors has an impact on the presentation in ultrasound: an analysis of 315 cases.
Wojcinski S; Stefanidou N; Hillemanns P; Degenhardt F
BMC Womens Health; 2013 Nov; 13():47. PubMed ID: 24252758
[TBL] [Abstract][Full Text] [Related]
6. HER2-positive breast cancer patients: correlation between mammographic and pathological findings.
Radenkovic S; Konjevic G; Isakovic A; Stevanovic P; Gopcevic K; Jurisic V
Radiat Prot Dosimetry; 2014 Nov; 162(1-2):125-8. PubMed ID: 25063784
[TBL] [Abstract][Full Text] [Related]
7. Is there a correlation between 3T multiparametric MRI and molecular subtypes of breast cancer?
Montemezzi S; Camera L; Giri MG; Pozzetto A; Caliò A; Meliadò G; Caumo F; Cavedon C
Eur J Radiol; 2018 Nov; 108():120-127. PubMed ID: 30396643
[TBL] [Abstract][Full Text] [Related]
8. Correlation between imaging features and molecular subtypes of breast cancer in young women (≤30 years old).
Huang J; Lin Q; Cui C; Fei J; Su X; Li L; Ma J; Zhang M
Jpn J Radiol; 2020 Nov; 38(11):1062-1074. PubMed ID: 32562180
[TBL] [Abstract][Full Text] [Related]
9. Survival time and molecular subtypes of breast cancer after radiotherapy in Thailand.
Kongsiang A; Tangvoraphonkchai V; Jirapornkul C; Promthet S; Kamsa-Ard S; Suwanrungruang K
Asian Pac J Cancer Prev; 2014; 15(23):10505-8. PubMed ID: 25556500
[TBL] [Abstract][Full Text] [Related]
10. Residual Mammographic Microcalcifications and Enhancing Lesions on MRI After Neoadjuvant Systemic Chemotherapy for Locally Advanced Breast Cancer: Correlation with Histopathologic Residual Tumor Size.
Kim YS; Chang JM; Moon HG; Lee J; Shin SU; Moon WK
Ann Surg Oncol; 2016 Apr; 23(4):1135-42. PubMed ID: 26628432
[TBL] [Abstract][Full Text] [Related]
11. Ultrasonographic features of triple-negative breast cancer: a comparison with other breast cancer subtypes.
Yang Q; Liu HY; Liu D; Song YQ
Asian Pac J Cancer Prev; 2015; 16(8):3229-32. PubMed ID: 25921124
[TBL] [Abstract][Full Text] [Related]
12. Retrospective study assessing the role of MRI in the diagnostic procedures for early breast carcinoma: a correlation of new foci in the MRI with tumor pathological features.
Calvo-Plaza I; Ugidos L; Miró C; Quevedo P; Parras M; Márquez C; de la Cruz JJ; Suárez-Gauthier A; Pérez FJ; Herrero M; Marcos M; García-Aranda M; Hidalgo M; Estévez LG
Clin Transl Oncol; 2013 Mar; 15(3):205-10. PubMed ID: 22872518
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer in the oldest old (≥ 89 years): Tumor characteristics, treatment choices, clinical outcomes and literature review.
Di Lascio S; Tognazzo E; Bigiotti S; Bonollo M; Costa A; Pagani O; Meani F
Eur J Surg Oncol; 2021 Apr; 47(4):796-803. PubMed ID: 33097334
[TBL] [Abstract][Full Text] [Related]
14. The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients.
Stein RG; Wollschläger D; Kreienberg R; Janni W; Wischnewsky M; Diessner J; Stüber T; Bartmann C; Krockenberger M; Wischhusen J; Wöckel A; Blettner M; Schwentner L;
BMC Cancer; 2016 Jul; 16():459. PubMed ID: 27411945
[TBL] [Abstract][Full Text] [Related]
15. CE-Magnetic Resonance Mammography for the evaluation of the contralateral breast in patients with diagnosed breast cancer.
Pediconi F; Venditti F; Padula S; Roselli A; Moriconi E; Giacomelli L; Catalano C; Passariello R
Radiol Med; 2005; 110(1-2):61-8. PubMed ID: 16163140
[TBL] [Abstract][Full Text] [Related]
16. Magnetic Resonance Imaging after Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate between No Residual Carcinoma and Residual Ductal Carcinoma In Situ in Patients with Triple-Negative Breast Cancer.
Park S; Yoon JH; Sohn J; Park HS; Moon HJ; Kim MJ; Kim EK; Kim SI; Park BW
PLoS One; 2016; 11(2):e0149347. PubMed ID: 26866475
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of triple-negative breast cancer: mammographic, US, and MR imaging features according to androgen receptor expression.
Bae MS; Park SY; Song SE; Kim WH; Lee SH; Han W; Park IA; Noh DY; Moon WK
Eur Radiol; 2015 Feb; 25(2):419-27. PubMed ID: 25224727
[TBL] [Abstract][Full Text] [Related]
18. [Detection of microcalcifications by high-resolution B-mode sonography in patients with BI-RADS 4a lesions].
Stöblen F; Landt S; Köninger A; Hecktor J; Kimmig R; Kümmel S
Gynakol Geburtshilfliche Rundsch; 2009; 49(4):292-8. PubMed ID: 20530944
[TBL] [Abstract][Full Text] [Related]
19. Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: Single-institution experience and review of published literature.
Meattini I; Bicchierai G; Saieva C; De Benedetto D; Desideri I; Becherini C; Abdulcadir D; Vanzi E; Boeri C; Gabbrielli S; Lucci F; Sanchez L; Casella D; Bernini M; Orzalesi L; Vezzosi V; Greto D; Mangoni M; Bianchi S; Livi L; Nori J
Eur J Surg Oncol; 2017 Apr; 43(4):642-648. PubMed ID: 27889196
[TBL] [Abstract][Full Text] [Related]
20. Is breast cancer from Sub Saharan Africa truly receptor poor? Prevalence of ER/PR/HER2 in breast cancer from Kenya.
Sayed S; Moloo Z; Wasike R; Bird P; Oigara R; Govender D; Kibera J; Carrara H; Saleh M
Breast; 2014 Oct; 23(5):591-6. PubMed ID: 25012047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]